New York State Common Retirement Fund
ERNA icon

New York State Common Retirement Fund’s Eterna Therapeutics ERNA Stock Holding History

New York State Common Retirement Fund’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Hold
0
– – – 3326
2022
Q2 		– Sell
-2
Closed -$14.4K – 3492
2022
Q1 		$26K Hold
2
– – ﹤0.01% 3267
2021
Q4 		$53K Hold
2
– – ﹤0.01% 3206
2021
Q3 		$119K Sell
2
-1
-33% -$86.3K ﹤0.01% 3085
2021
Q2 		$367K Buy
+3
New +$432K ﹤0.01% 2760

Other funds holding ERNA

LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IC
Inverness Counsel New York $1.8B AUM 9.9% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

New York State Common Retirement Fund's ERNA Position: Q3 2022 in Review

New York State Common Retirement Fund held its Eterna Therapeutics (ERNA) position steady in Q3 2022 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3326.

New York State Common Retirement Fund first reported a position in ERNA in Q2 2021 and has held it in 4 quarters since. The position peaked at $367K in Q2 2021. 31 funds tracked by Wall St. Rank hold ERNA as of Q3 2022.

  • New York State Common Retirement Fund held 0 shares of Eterna Therapeutics worth $0 as of Q3 2022.
  • New York State Common Retirement Fund left its Eterna Therapeutics share count unchanged in Q3 2022.
  • Eterna Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q3 2022, its #3326 holding.
  • New York State Common Retirement Fund first reported a position in Eterna Therapeutics in Q2 2021 and has held it in 4 quarters since.
  • New York State Common Retirement Fund's Eterna Therapeutics position peaked at $367K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.